Lack of pharmacokinetic interaction between nelfinavir and nevirapine

被引：35
|
作者：
Skowron, G
Leoung, C
Kerr, B
Dusek, A
Anderson, R
Beebe, S
Grosso, R
机构：
[1] Brown Univ, Roger Williams Gen Hosp, Sch Med, Dept Med,Div Infect Dis, Providence, RI 02908 USA
[2] St Francis Mem Hosp, San Francisco, CA USA
[3] Agouron Pharmaceut Inc, La Jolla, CA USA
[4] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[5] Bristol Myers Squibb, Princeton, NJ USA
来源：
AIDS | 1998年 / 12卷 / 10期
关键词：
nelfinavir; nevirapine; pharmacokinetics; P450; HIV; drug interaction;
D O I：
10.1097/00002030-199810000-00017
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1243 / 1244
页数：2
相关论文
共 50 条
  • [31] Pharmacokinetic Modeling of Simvastatin, Nelfinavir and Their Interaction in Humans
    Methaneethorn, Janthima
    Kunyamee, Patcharaporn
    Jindasri, Warangkana
    Wattanasaovaluk, Warunee
    Kraiboot, Anoot
    Lohitnavy, Manupat
    2014 36TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2014, : 5715 - 5718
  • [32] Does nelfinavir interact with nevirapine?
    Reactions Weekly, 1998, 714 (1) : 4 - 4
  • [33] dNN Study: stavudine, nelfinavir and nevirapine. Preliminary safety, activity and pharmacokinetic interactions
    Skowron, G
    ANTIVIRAL THERAPY, 1998, 3 : 61 - 62
  • [34] Lack of pharmacokinetic interaction between nebivolol and spironolactone.
    Morton, TL
    Tu, HC
    Liu, S
    Chervenick, SW
    Rackley, RJ
    Huang, MY
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P46 - P46
  • [35] Lack of pharmacokinetic interaction between derazantinib and naringin in rats
    Liu, Ya-nan
    Chen, Jie
    Xu, Xinhao
    Hu, Yingying
    Hu, Jin-yu
    Xu, Ren-ai
    Lin, Guanyang
    PHARMACEUTICAL BIOLOGY, 2023, 61 (01) : 514 - 519
  • [36] Lack of a pharmacokinetic interaction between ezetimibe and atorvastatin.
    Zhu, Y
    Statkevich, P
    Kosoglou, T
    Maxwell, SE
    Anderson, L
    Patrick, JE
    Batra, V
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P68 - P68
  • [37] LACK OF PHARMACOKINETIC INTERACTION BETWEEN DAPAGLIFLOZIN AND PIOGLITAZONE IN HEALTHY
    Li, T.
    Roche, J.
    Zhang, W.
    Pfister, M.
    Liu, X.
    Usansky, H.
    Maurer, C.
    Shyu, W.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1093 - 1093
  • [38] LACK OF PHARMACOKINETIC INTERACTION BETWEEN DAPAGLIFLOZIN AND METFORMIN IN HEALTHY
    Zhang, W.
    Yones, C.
    Dorizio, S.
    Pfister, M.
    Liu, X.
    Feng, Y.
    Kasichayanula, S.
    Shyu, W.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1094 - 1094
  • [39] Lack of a pharmacokinetic interaction between indinavir and methadone.
    Cantilena, L
    McCrea, J
    Blazes, D
    Winchell, G
    Carides, A
    Royce, C
    Deutsch, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 135 - 135
  • [40] Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil
    Periclou, AP
    Ventura, D
    Sherman, T
    Rao, N
    Abramowitz, WT
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (09) : 1389 - 1394
12345